Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

aspen pharma trading limited - estriolum inn - tafla - 2 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

orifarm generics a/s - tibolonum inn - tafla - 2,5 mg

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

pfizer europe ma eeig - estrógenum samtengdum, bazedoxifene - postmenopause - samtengdum estrógen og bazedoxifene - duavive er ætlað til:meðferð estrógen skort einkenni í tíðahvörf konur með leg (með að minnsta kosti 12 mánuði síðan síðast tíða) fyrir hvern meðferð með the-inniheldur meðferð er ekki viðeigandi. reynsla ritgerð konur eldri en 65 ára er takmörkuð.

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

astrazeneca ab - fulvestrant - brjóstakrabbamein - annarra meðferð, anti-estrógen - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. , Í leik - eða perimenopausal konur, samsetningu meðferð með palbociclib ætti að vera ásamt blóðkornunum á nýja-sjálandi (lhrh) örva.

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - hinsveiflur og heilahimnubólur og hliðstæður - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

novo nordisk a/s* - estradiol; norethisteronum acetat - filmuhúðuð tafla

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

novo nordisk a/s* - norethisteronum acetat; estradiol - filmuhúðuð tafla

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

novo nordisk a/s* - norethisteronum acetat; estradiolum inn - filmuhúðuð tafla - 1mg/0,5 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

novo nordisk a/s* - estradiolum inn - filmuhúðuð tafla - 1 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

novo nordisk a/s* - estradiolum inn - filmuhúðuð tafla - 2 mg